Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02483494
Other study ID # 2014\00793
Secondary ID RG2013/03
Status Recruiting
Phase N/A
First received June 23, 2015
Last updated August 3, 2017
Start date July 8, 2015
Est. completion date June 30, 2018

Study information

Verified date August 2017
Source National University Heart Centre, Singapore
Contact Karen Koh
Phone +65 6772 6884
Email karen_wl_koh@nuhs.edu.sg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim. To develop and examine the effectiveness of an APN-led telehealth rehabilitative programme as a transitional nursing therapeutic on readmission rates and health related outcomes amongst patients with Acute Myocardial Infarction (AMI) post discharge.

Design. Randomized controlled trial with repeated measures.

Methodology. A consecutive sampling of 172 patients with AMI will be recruited from a tertiary hospital in Singapore. Participants will be randomised into two groups. The experimental group (ALTRA) will receive APN-led telehealth rehabilitative programme upon discharge in addition to standard care. The control group will receive only standard follow-up care.


Description:

Ischaemic heart disease is the third leading cause both for death and illness for hospitalisation in Singapore. Epidemiological data shows that the incidence of acute myocardial infarction (AMI) stands around 7000 plus in Singapore. In United States, nearly 20% of patients with AMI are readmitted within 30 days of discharge causing the healthcare system a huge financial burden. These readmissions have been shown to be associated with lower patient satisfaction and less inefficient healthcare.

Cardiac rehabilitation has been proven to be an effective strategy in improving quality of life and reducing readmission. However, this structured programme which comprise of clinical review, education and exercise, has poor uptake rate for varied reasons. It is important that newer strategies are being explored and developed to cater to the changing needs of the patient population. One of which is to utilize telemedicine with combination of Advanced Practice Nurse delivering the care remotely.

This is a substudy of IMMACULATE STUDY (NCT02468349) where more details can be found.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date June 30, 2018
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria:

- Typical history of ischemic chest pain or angina equivalent symptoms (e.g. acute onset dyspnea)> 30 minutes

- Undergone PCI for index event

- NT-Pro-BNP =1000 ng/L

- Cinically diagnosed AMI at high risk of ventricular remodeling (STEMI or NSTEMI):

(Anterior or large inferior STEMI)

- ECG changes>0.1mV ST segment elevation in two or more contiguous limb leads or precordial leads or

- Presence of pathological Q waves in two or more contiguous limb leads or precordial leads.

- Typical rise or fall of cardiac enzymes (cardiac troponin value exceeding the 99th percentile).

- Angiographic findings of proximal/mid LAD, proximal LCX or RCA occlusion for STEMI.

(Or NSTEMI with)

- Typical rise or fall of cardiac enzymes (cTn value exceeding the 99th percentile).

- Peak cTnI should be >10ug/L, TnT-hs>250 ng/L or CK-MB >80 IU/L

- LVEF (echocardiography) = 40% or Kilip class =2

Exclusion Criteria:

- Hypersensitivity to ticagrelor, aspirin or any excipients

- Active pathological bleeding

- History of intracranial haemorrhage

- Infection within 6 weeks preceding the primary angioplasty, inflammatory disorders, Hepatitis, HIV, autoimmune disease or on immunosuppressive therapy

- Women of childbearing potential, known to be pregnant, breast-feeding, or intend to become pregnant during the study period.

- History of non-ischaemic cardiomyopathy or malignancy

- History of significant valvular heart disease (moderate or severe MS, MR, AS, AR, TR)

- Planned CABG within the next 6 weeks

- Cardiogenic shock unable to be weaned off inotropes or IABP

- Asthma or any other contraindications to beta-blockers

- Arrhythmias precluding proper CMR image acquisition, including atrial fibrillation and frequent atrial or ventricular ectopy of > 1 in 5 intrinsic ECG complexes

- Contraindications to cardiac magnetic resonance imaging including claustrophobia, pacemaker or ICD implantation, mechanical valve or other metallic implants

- Significant liver impairment

- Renal impairment (eGFR<45 ml min -1), end stage renal failure on renal replacement therapy

- Anaemia (Hb<10 g/dL)

- Psychosocial barriers to telemedicine adoption (screening for education level, dementia, substance abuse and other psychological disorders)

- Participants who cannot be followed up

- Participants not able or willing to consent for study

Study Design


Intervention

Other:
APN-led Telemedicine
Allocation to experimental or Usual care is 1:1. The four study APNs will be delivering the care and have at least three years working experiences in coronary care settings. A telephonic script and study protocol is made available to ensure standardization of intervention.

Locations

Country Name City State
Singapore National University Hospital Kent Ridge

Sponsors (2)

Lead Sponsor Collaborator
National University Heart Centre, Singapore National University Hospital, Singapore

Country where clinical trial is conducted

Singapore, 

References & Publications (1)

Young W, Rewa G, Goodman SG, Jaglal SB, Cash L, Lefkowitz C, Coyte PC. Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial. CMAJ. 2003 Oct 28;169(9):905-10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Readmissions Days Cardiac and non-cardiac causes Readmission days per 1000 follow up days will be calculated using the total number of sample in that arm x follow days (i.e. 30 days in this instance) as the denominator. (Please refer to references attached) 30 days
Secondary Readmissions Days Per 1000 follow up days Cardiac and non-cardiac causes 6 months
Secondary ED visits or unplanned self-reported doctor visits Cardiac and non-cardiac causes 6 months
Secondary Cardiac Self-Efficacy Scale Health Related Outcomes 6 months
Secondary Myocardial Infarction Dimension Assessment Scale Health Related Outcomes 6 months
Secondary EuroQoL Health Related Outcomes 6 months
Secondary Hospital Anxiety and Depression Scale Health Related Outcomes 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study